Literature DB >> 31440315

Preventing brain embolism by using a modified isolation technique in transcatheter aortic valve implantation for a patient with shaggy and porcelain aorta.

Yoshikatsu Nomura1, Motoharu Kawashima1, Kanetsugu Nagao1, Shota Hasegawa1, Takanori Tsujimoto1, So Izumi1, Masamichi Matsumori1, Tasuku Honda1, Kenzo Uzu2, Nobuyuki Takahashi2, Takahiro Sawada2, Tetsuari Onishi2, Yoshinori Yasaka2, Hirohisa Murakami1, Nobuhiko Mukohara1.   

Abstract

Transcatheter aortic valve implantation (TAVI) has become a useful and effective treatment for surgical high-risk patients with severe aortic valve stenosis (AS). Stroke is one of the most frequent complications associated with TAVI. Shaggy and porcelain aortas are a risk factor for procedure-related strokes. Preventing brain embolism is one of the most important goals in patients with diseased aortas. We present a case where we performed TAVI in an 89-year-old man with severe AS, a shaggy aorta, a porcelain aorta, and congestive heart failure. TAVI via a transfemoral approach was performed using a modified isolation technique with cannulation from bilateral axillary arteries and cardiopulmonary bypass to prevent brain embolism. The catheter-delivered embolic protection device is necessary to pass the diseased aorta, but the modified isolation technique can be used without any contact with the shaggy aorta. Embolism did not occur, and his heart failure improved immediately. <Learning objective: Transcatheter aortic valve implantation (TAVI) is a therapeutic option for patients with severe aortic stenosis considered to be at high risk for aortic valve replacement. Cerebral embolism is the most frequent complication of TAVI. A shaggy or porcelain aorta is associated with a high risk of stroke during TAVI. We report a case of TAVI in a shaggy and porcelain aorta and prevention of cerebral embolism by adopting a modified isolation technique without using conventional protection devices.>.

Entities:  

Keywords:  Porcelain aorta; Shaggy aorta; Transcatheter aortic valve implantation

Year:  2019        PMID: 31440315      PMCID: PMC6698247          DOI: 10.1016/j.jccase.2019.04.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Embolic Protection Devices During TAVI: Current Evidence and Uncertainties.

Authors:  Omar Abdul-Jawad Altisent; Rishi Puri; Josep Rodés-Cabau
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2016-09-13

Review 2.  A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.

Authors:  Hemang B Panchal; Vatsal Ladia; Parthiv Amin; Parthavkumar Patel; Sreenivas P Veeranki; Kais Albalbissi; Timir Paul
Journal:  Am J Cardiol       Date:  2014-09-28       Impact factor: 2.778

3.  Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis.

Authors:  Gennaro Giustino; Sabato Sorrentino; Roxana Mehran; Michela Faggioni; George Dangas
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

4.  Clinical outcomes at 1 year following transcatheter aortic valve replacement.

Authors:  David R Holmes; J Matthew Brennan; John S Rumsfeld; David Dai; Sean M O'Brien; Sreekanth Vemulapalli; Fred H Edwards; John Carroll; David Shahian; Fred Grover; E Murat Tuzcu; Eric D Peterson; Ralph G Brindis; Michael J Mack
Journal:  JAMA       Date:  2015-03-10       Impact factor: 56.272

5.  Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.

Authors:  Israel M Barbash; Danny Dvir; Itsik Ben-Dor; Salem Badr; Petros Okubagzi; Rebecca Torguson; Paul J Corso; Zhenyi Xue; Lowell F Satler; Augusto D Pichard; Ron Waksman
Journal:  Am J Cardiol       Date:  2013-02-12       Impact factor: 2.778

6.  Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study.

Authors:  Philipp Kahlert; Stephan C Knipp; Marc Schlamann; Matthias Thielmann; Fadi Al-Rashid; Marcel Weber; Uwe Johansson; Daniel Wendt; Heinz G Jakob; Michael Forsting; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

Review 7.  Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis.

Authors:  Rodrigo Bagur; Karla Solo; Saleh Alghofaili; Luis Nombela-Franco; Chun Shing Kwok; Samual Hayman; Reed A Siemieniuk; Farid Foroutan; Frederick A Spencer; Per O Vandvik; Tim G Schäufele; Mamas A Mamas
Journal:  Stroke       Date:  2017-04-14       Impact factor: 7.914

8.  Isolation technique for stroke prevention in patients with a mobile atheroma.

Authors:  N Shiiya; T Kunihara; Y Kamikubo; K Yasuda
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

9.  "Shaggy" aorta syndrome with atheromatous embolization to visceral vessels.

Authors:  L H Hollier; F J Kazmier; J Ochsner; J C Bowen; C D Procter
Journal:  Ann Vasc Surg       Date:  1991-09       Impact factor: 1.466

Review 10.  Aortic arch replacement for degenerative aneurysms: advances during the last decade.

Authors:  Norihiko Shiiya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.